TYP Glucose balance
Natural health product licensed in Canada
- Licence holder
- TYP Pharmaceutical Ltd.
- NPN or DIN-HM
- 80040505
- Status
- Active licence
- Licence date
- 5 March 2013
- Revision date
- 20 December 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide DL-alpha-lipoïque | 150 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Helps to promote healthy glucose metobalism. Provides antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If pregnant, do not use this product.
- Effets indésirables connus
Hypersensitivity/allergy may occur. In such a case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are breastfeeding. Consult a health care practitioner prior to use if you have diabetes. If symptoms persist or worsen, consult a health care practitioner. Discontinue use and consult a health care practitioner if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80040505
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging